Manatuck Hill Partners, LLC Chembio Diagnostics, Inc. Transaction History

Manatuck Hill Partners, LLC

  • $230 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$3.18 - $15.54 $206,700 - $1.01 Million
-65,000 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$2.36 - $5.6 $153,400 - $364,000
65,000 New
65,000 $333,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Manatuck Hill Partners, LLC Portfolio

Follow Manatuck Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manatuck Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manatuck Hill Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email